1. Home
  2. OEC vs DCTH Comparison

OEC vs DCTH Comparison

Compare OEC & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion S.A.

OEC

Orion S.A.

HOLD

Current Price

$7.66

Market Cap

319.6M

Sector

Industrials

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.82

Market Cap

363.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OEC
DCTH
Founded
1862
1988
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.6M
363.5M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
OEC
DCTH
Price
$7.66
$10.82
Analyst Decision
Sell
Strong Buy
Analyst Count
4
4
Target Price
$6.56
$22.00
AVG Volume (30 Days)
420.7K
454.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.11%
N/A
EPS Growth
N/A
107.53
EPS
N/A
N/A
Revenue
$1,806,700,000.00
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
$2.21
$33.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$8.12
52 Week High
$12.10
$17.34

Technical Indicators

Market Signals
Indicator
OEC
DCTH
Relative Strength Index (RSI) 59.14 48.42
Support Level $5.96 $10.29
Resistance Level $8.40 $11.14
Average True Range (ATR) 0.36 0.52
MACD 0.03 -0.10
Stochastic Oscillator 84.39 16.20

Price Performance

Historical Comparison
OEC
DCTH

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: